What is Greenrose Acquisition Corp. (GNRSW) stock price today?

Greenrose Acquisition Corp. (GNRSW) is currently trading at $0.00.

What is GNRSW P/E ratio?

Greenrose Acquisition Corp.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is GNRSW return on equity (ROE)?

Greenrose Acquisition Corp.'s return on equity (ROE) is 26.09%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Greenrose Acquisition Corp.'s market cap?

Greenrose Acquisition Corp. has a market capitalization of $1768.

OTC · Drug Manufacturers - Specialty & Generic

Greenrose Acquisition Corp. (GNRSW) Stock

$0.00 OTC: GNRSW Healthcare

Greenrose Holding Company Inc., operating via its subsidiaries, specializes in the manufacturing and commercialization of cannabis products. Its core business functions include cultivating, processing, and packaging medicinal cannabis and its related derivative items.

Valuation

Metric	Value
Price	$0.00
Market Cap	$1768
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$1.12
52-Week High	$6.00
52-Week Low	—
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	26.09%
ROA	7.53%
ROCE	9.10%
Gross Margin	36.00%
Operating Margin	40.00%
Net Margin	72.00%
Debt/Equity	1.58
Current Ratio	0.21

Annual Financials (USD)

Metric	2019	2020	2021
Revenue	$0	$28.0M	$25.0M
Operating Profit	$0	$16.0M	$10.0M
Net Profit	$0	$1.0M	$18.0M
EPS	$0.00	$3.46	$1.12
Op Margin	—	55.0%	38.7%

Balance Sheet (USD)

Metric	2019	2020	2021
Total Assets	$1.0M	$174.0M	$239.0M
Total Liabilities	$1.0M	$1.0M	$170.0M
Cash	$0	$0	$7.0M
Borrowings	$1.0M	$1.0M	$109.0M

Latest News

/C O R R E C T I O N -- Agoda/ PR Newswire · Aug 11, 2026 Why Dentsply Sirona (XRAY) Stock Is Trading Lower Today StockStory · Aug 11, 2026 Central Processing Units Could Be New Growth Driver for TSMC The Wall Street Journal · Aug 11, 2026 Why Are Funko (FNKO) Shares Soaring Today StockStory · Aug 11, 2026 Surf Air Mobility Q2 Earnings Call Highlights MarketBeat · Aug 11, 2026

Cash Flow (USD)

Metric	2019	2020	2021
Operating Cash Flow	$0	$-1.0M	$8.0M
Investing Cash Flow	$0	$-173.0M	$-122.0M
Financing Cash Flow	$0	$0	$-59.0M
Net Cash Flow	$0	$0	$7.0M
Free Cash Flow	$0	$-2.0M	$3.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	4.51
FCF Yield	149490.95%
Quick Ratio	0.11
Interest Coverage	4.48
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BLEVFBeleave Inc.	$0.00	—	0.00	$566	0.00%
EPRSQEPIRUS Biopharmaceuticals, Inc.	$0.00	—	—	$1571	0.00%
GWHPGlobal WholeHealth Partners Corporation	$0.00	—	0.00	$1313	0.00%
INTPIntegrated Pharmaceuticals, Inc.	$0.00	—	—	$1787	0.00%
MLTOMEDirect Latino, Inc.	$0.00	—	—	$1700	0.00%

About Greenrose Acquisition Corp.

Greenrose Acquisition Corp. (GNRSW) stock trades at $0.00 with a market capitalization of $1768. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00.

On profitability, Greenrose Acquisition Corp. generates a return on equity (ROE) of 26.09% — well above the market average, a sign of a high-quality business, return on capital employed of 9.10%, an operating margin of 40.00%, a net profit margin of 72.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides